Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
- PMID: 30219397
- PMCID: PMC6682609
- DOI: 10.1016/j.jcmg.2018.07.015
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
Abstract
Objectives: This study sought to investigate the association between the extent, location, and pattern of late gadolinium enhancement (LGE) and outcome in a large dilated cardiomyopathy (DCM) cohort.
Background: The relationship between LGE and prognosis in DCM is incompletely understood.
Methods: The authors examined the association between LGE and all-cause mortality and a sudden cardiac death (SCD) composite based on the extent, location, and pattern of LGE in DCM.
Results: Of 874 patients (588 men, median age 52 years) followed for a median of 4.9 years, 300 (34.3%) had nonischemic LGE. Estimated adjusted hazard ratios for patients with an LGE extent of 0 to 2.55%, 2.55% to 5.10%, and >5.10%, respectively, were 1.59 (95% confidence interval [CI]: 0.99 to 2.55), 1.56 (95% CI: 0.96 to 2.54), and 2.31 (95% CI: 1.50 to 3.55) for all-cause mortality, and 2.79 (95% CI: 1.42 to 5.49), 3.86 (95% CI: 2.09 to 7.13), and 4.87 (95% CI: 2.78 to 8.53) for the SCD endpoint. There was a marked nonlinear relationship between LGE extent and outcome such that even small amounts of LGE predicted a substantial increase in risk. The presence of septal LGE was associated with increased mortality, but SCD was most associated with the combined presence of septal and free-wall LGE. Predictive models using LGE presence and location were superior to models based on LGE extent or pattern.
Conclusions: In DCM, the presence of septal LGE is associated with a large increase in the risk of death and SCD events, even when the extent is small. SCD risk is greatest with concomitant septal and free-wall LGE. The incremental value of LGE extent beyond small amounts and LGE pattern is limited.
Keywords: cardiovascular magnetic resonance; dilated cardiomyopathy; late gadolinium enhancement.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/fx1.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/gr1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/gr2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/gr3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/gr4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6682609/bin/gr5.gif)
Comment in
-
Are We Ready to Treat Dilated Cardiomyopathy Differently, Using LGE Guidance?JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1656-1658. doi: 10.1016/j.jcmg.2018.08.005. Epub 2018 Sep 12. JACC Cardiovasc Imaging. 2019. PMID: 30219396 No abstract available.
Similar articles
-
Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.J Cardiovasc Magn Reson. 2018 Jun 14;20(1):36. doi: 10.1186/s12968-018-0466-7. J Cardiovasc Magn Reson. 2018. PMID: 29898740 Free PMC article.
-
The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284. doi: 10.1016/j.jcmg.2018.03.006. Epub 2018 Apr 18. JACC Cardiovasc Imaging. 2018. PMID: 29680351 Review.
-
Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e006233. doi: 10.1161/CIRCEP.117.006233. Circ Arrhythm Electrophysiol. 2018. PMID: 29654132
-
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.JACC Heart Fail. 2017 Jan;5(1):28-38. doi: 10.1016/j.jchf.2016.09.017. Epub 2016 Dec 21. JACC Heart Fail. 2017. PMID: 28017348 Review.
-
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.JAMA. 2013 Mar 6;309(9):896-908. doi: 10.1001/jama.2013.1363. JAMA. 2013. PMID: 23462786
Cited by
-
Evaluation of deep learning-based reconstruction late gadolinium enhancement images for identifying patients with clinically unrecognized myocardial infarction.BMC Med Imaging. 2024 May 31;24(1):127. doi: 10.1186/s12880-024-01308-2. BMC Med Imaging. 2024. PMID: 38822240 Free PMC article.
-
Risk Prediction, Diagnosis and Management of a Breast Cancer Patient with Treatment-Related Cardiovascular Toxicity: An Essential Overview.Cancers (Basel). 2024 May 11;16(10):1845. doi: 10.3390/cancers16101845. Cancers (Basel). 2024. PMID: 38791923 Free PMC article. Review.
-
Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis.PeerJ. 2024 Apr 23;12:e17201. doi: 10.7717/peerj.17201. eCollection 2024. PeerJ. 2024. PMID: 38680895 Free PMC article.
-
Ventricular predominance in biventricular arrhythmogenic cardiomyopathy: Should new subtype criteria be recognized?Radiol Case Rep. 2024 Mar 28;19(6):2457-2463. doi: 10.1016/j.radcr.2024.03.014. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38585407 Free PMC article.
-
Fibrosis modeling choice affects morphology of ventricular arrhythmia in non-ischemic cardiomyopathy.Front Physiol. 2024 Mar 18;15:1370795. doi: 10.3389/fphys.2024.1370795. eCollection 2024. Front Physiol. 2024. PMID: 38567113 Free PMC article.
References
-
- Gulati A., Jabbour A., Ismail T.F. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896–908. - PubMed
-
- Maceira A.M., Prasad S.K., Khan M., Pennell D.J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417–426. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical